Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-03

FDA Approved: TAVABOROLE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved Tavaborole as a generic product under an Original Application (ANDA 211963) for Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tavaborole (Tavaborole)

Snippet

ORIG AP for TAVABOROLE (TAVABOROLE)